Altered nuclease activity has been associated with different human conditions, underlying its potential as a biomarker. The modular and easy to implement screening methodology presented in this paper allows the selection of specific nucleic acid probes for harnessing nuclease activity as a biomarker of disease.
Balian, A., Garcia Gonzalez, J., Bastida, N., Akhtar, K. K., Borsa, B. A., Hernandez, F. J. Kinetic Screening of Nuclease Activity using Nucleic Acid Probes. J. Vis. Exp. (153), e60005, doi:10.3791/60005 (2019).